Home
Forums
New posts
Search forums
What's new
New posts
Latest activity
Members
Current visitors
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Brown Cafe Community Center
Current Events
Coronavirus
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Old Man Jingles" data-source="post: 4468511" data-attributes="member: 18222"><p>It's already been done.</p><p>I posted it several days ago.</p><p>It is done by embedding UV-A lights (Ultraviolet A (UVA) 315 – 400 nm) in the intubation hose.</p><p></p><p><strong>Proof of Concept</strong></p><p>An abstract led by the team at <a href="https://apnews.com/b44f4531071e6204023f7b8e16f59d4b" target="_blank">Cedars-Sinai Medical Center</a> was published in the United European Gastroenterology Journal, October 2019, titled “Internally Applied Ultraviolet Light as a Novel Approach for Effective and Safe Anti-Microbial Treatment.” Here, the authors show that UVA light exhibits significant in vitro bactericidal effects in an array of clinically important bacteria. Additionally, this is the first study using intracolonic UVA application, which reports that UVA exposure is not associated with endoscopic or histologic injury. These findings suggest that UVA therapy can potentially provide a safe and effective novel approach to antimicrobial treatment via phototherapy on internal organs.</p><p></p><p><a href="https://www.ueg.eu/education/document/internally-applied-ultraviolet-light-as-a-novel-approach-for-effective-and-safe-anti-microbial-treatment/208958/" target="_blank">Abstract Document</a></p><p></p><p><span style="font-size: 22px"><strong><a href="https://apnews.com/b44f4531071e6204023f7b8e16f59d4b" target="_blank">Aytu BioScience Signs Exclusive Global License with Cedars-Sinai for Potential Coronavirus Treatment</a></strong></span></p><p>April 20, 2020</p><p></p><p>The Company <strong>Aytu</strong> is engaging with the research team at Cedars-Sinai and the FDA to determine an expedited regulatory process to potentially enable near-term use of the technology initially as a coronavirus intervention for critically ill intubated patients.</p><p></p><p>Disbrow continued, “This first-in-class technology has the potential to be a game changer for clinicians treating patients infected with coronavirus and other respiratory conditions, and our team is working tirelessly alongside the Cedars-Sinai team to determine the safety and effectiveness of this device in humans.”</p></blockquote><p></p>
[QUOTE="Old Man Jingles, post: 4468511, member: 18222"] It's already been done. I posted it several days ago. It is done by embedding UV-A lights (Ultraviolet A (UVA) 315 – 400 nm) in the intubation hose. [B]Proof of Concept[/B] An abstract led by the team at [URL='https://apnews.com/b44f4531071e6204023f7b8e16f59d4b']Cedars-Sinai Medical Center[/URL] was published in the United European Gastroenterology Journal, October 2019, titled “Internally Applied Ultraviolet Light as a Novel Approach for Effective and Safe Anti-Microbial Treatment.” Here, the authors show that UVA light exhibits significant in vitro bactericidal effects in an array of clinically important bacteria. Additionally, this is the first study using intracolonic UVA application, which reports that UVA exposure is not associated with endoscopic or histologic injury. These findings suggest that UVA therapy can potentially provide a safe and effective novel approach to antimicrobial treatment via phototherapy on internal organs. [URL='https://www.ueg.eu/education/document/internally-applied-ultraviolet-light-as-a-novel-approach-for-effective-and-safe-anti-microbial-treatment/208958/']Abstract Document[/URL] [SIZE=6][B][URL='https://apnews.com/b44f4531071e6204023f7b8e16f59d4b']Aytu BioScience Signs Exclusive Global License with Cedars-Sinai for Potential Coronavirus Treatment[/URL][/B][/SIZE] April 20, 2020 The Company [B]Aytu[/B] is engaging with the research team at Cedars-Sinai and the FDA to determine an expedited regulatory process to potentially enable near-term use of the technology initially as a coronavirus intervention for critically ill intubated patients. Disbrow continued, “This first-in-class technology has the potential to be a game changer for clinicians treating patients infected with coronavirus and other respiratory conditions, and our team is working tirelessly alongside the Cedars-Sinai team to determine the safety and effectiveness of this device in humans.” [/QUOTE]
Insert quotes…
Verification
Post reply
Home
Forums
Brown Cafe Community Center
Current Events
Coronavirus
Top
